Dr. Griggs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Crittenden Blvd
Rochester, NY 14642Phone+1 585-275-2541Fax+1 585-276-2056
Education & Training
University of RochesterResidency, Internal Medicine, 1968 - 1971
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1965 - 1966- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Transitional Year, 1964 - 1965
Perelman School of Medicine at the University of PennsylvaniaClass of 1964
Certifications & Licensure
NY State Medical License 1971 - 2024
FL State Medical License 2014 - 2017
OH State Medical License 1965 - 1976- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1998
- Top MD Consumers Checkbook
Clinical Trials
- Characteristics of Andersen-Tawil Syndrome Start of enrollment: 2007 Nov 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 71 citationsEarly and late losses of motor units after poliomyelitis.Alan J. McComas, Caroline Quartly, Robert C. Griggs
Brain. 1997-08-01 - 25 citationsRandomized, double-blind trial of mazindol in Duchenne dystrophy.Robert C. Griggs, Richard T. Moxley, J. R. Mendell, Gerald M. Fenichel, Michael H. Brooke
Muscle & Nerve. 1990-12-01 - 52 citationsEffect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.Michela Guglieri, Kate Bushby, Michael P McDermott, Kimberly A Hart, Rabi Tawil
JAMA. 2022-04-19
Press Mentions
Where There Is Debate on the ‘Persuasive Evidence’ That Exon-Skipping Therapies Work for Duchenne Muscular DystrophyAugust 15th, 2019
Robert C. Griggs, MD, FAAN on Serving as Neurology® Editor-in-Chief - American Academy of NeurologyMay 21st, 2018
Editors' NoteDecember 5th, 2017- Join now to see all
Committees
- Author, Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular and Electrodiagnostic Medicine 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
